FOX BIZ NEWS: Novavax starts Phase 1 coronavirus vaccine trial after $388M from Bill Gates-backed group


Novavax starts Phase 1 coronavirus vaccine trial after $388M from Bill Gates-backed group



If Phase 1 is successful, Novavax will follow up with Phase 2 in multiple countries, including the U.S.

Comments

Popular posts from this blog

Covid live: Record 50,000+ infections on Sunday

Impact of pandemic? Women jobseekers fell by 34% in 2021

SC slams trial courts for seeking needless custody